openPR Logo
Press release

Orthopaedic Oncology Market Dynamics, Segments and Supply Demand 2016-2026

08-24-2016 04:30 PM CET | Health & Medicine

Press release from: Future Market Insights

Orthopaedic Oncology Market Dynamics, Segments and Supply

Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016, the American Cancer Society estimates about 3,300 new cases for cancer of the bones and joints and 12,310 new cases for soft tissue sarcomas. There are three main types of bone cancers, osteosarcoma, which arises most often in the growing ends of long bones, chondrosarcoma, which develops in the metaphysis and Ewing’s sarcoma. Malignant bone tumors also referred to as chondrosarcoma are more prevalent in adults than other form of cancers and remains a challenging tumor to diagnose and treat. Treatment with chemotherapy and radiotherapy do not remain the preferred choice of treatment in treating such type of tumor as clinical studies demonstrate no substantial improvements in the survival rate of the patients. Therefore, adequate surgical resection is the mainstay of treatment in case of chondrosarcoma. As estimated by the American Cancer Society, chondrosarcomas is more prevalent with 40% of cases developing in adults whereas less than 5% of cases occur in patients younger than 20.

Radiofrequency ablation has become the standard and most preferred choice of treatment in case of osteoid osteoma, a benign bone tumor that arises from osteoblasts. However studies demonstrates its expanded application in palliative treatment of patients with painful bone metastasis .The ability to perform less invasive procedures often allows more efficient, less painful, and more cost-effective patient care. In addition, minimally invasive techniques such as kyphoplasty, vertebroplasty, and acetabuloplasty may provide an alternative to major reconstructive surgery for patients with metastatic disease.

Global Orthopaedic Oncology Market: Drivers & Restraints

Factors driving the global orthopedic oncology market includes rapidly ageing population with increasing risk of developing cancer. Patients who had prior high-dose external radiation therapy or treatment with anti-cancer drugs are at higher risk of developing osteosarcoma. However, a small number of bone cancers also develop due to heredity defects of bones and people with metal implants, which doctors sometimes use to repair fractures, are more likely to develop osteosarcoma. In case of soft tissue sarcoma adults with heredity disorders such as retinoblastoma, tuberous sclerosis, werner syndrome etc are at higher side of developing this type of cancer.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1523

High cost associated with the treatment for musculoskeletal oncology diseases and lack of awareness regarding the effective treatment therapies are some of the factors which restraint the market growth in the near future

Global Orthopaedic Oncology Market: Segmentation

Orthopedic Oncology marketis segmented by treatment, by end user and geography:

By Treatment

Surgery

Amputation

Limb Salvage Surgery

Reconstructive Surgery

Chemotherapy

Radiation Therapy

Targeted Therapy

By End User

Multispecialty Hospitals

Cancer Research Institutes

Global Orthopaedic Oncology Market: Overview

Rising prevalence of musculoskeletal disorders are expected to drive the demand for effective treatment therapies for treatment of various cancers associated with bones and soft tissues. The orthopaedic oncology market is expected to grow at a healthy pace attributed to rising prevalence of cancer over the forecasted period.

Global Orthopaedic Oncology Market: Region-wise Outlook

On the basis of region presence, thrombophilia treatment market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. Global market for Orthopediac oncology is expected to be on a higher side in North America and Europe owing to increasing prevalence of cancer and musculoskeletal related disorders. Asia pacific represents immense growth opportunity for orthopedic oncology market attributed to rapidly aging population and rising cancer incidence. In addition macroeconomic factors such as FDA approvals are also expected to increase the adoption rate of devices in the developed countries.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1523

Global Orthopaedic Oncology Market: Key Players

Some of the key market players in the orthopedic oncology market are Stryker Corporation, Accentus Inc., Roche Diagnostics, Amgen Inc., Novartis AG, Biogen Idec, GlaxoSmithKline, Sanofi S.A., and Pfizer Inc.

ABOUT US:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

CONTACT:
Future Market Insights
616 Corporate Way,
Suite 2-9018,
Valley Cottage,
New York 10989,
United States
Tel: +1-347-918-3531
Fax: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orthopaedic Oncology Market Dynamics, Segments and Supply Demand 2016-2026 here

News-ID: 358147 • Views: 643

More Releases from Future Market Insights

Hormone Replacement Therapy Market COVID-19 Impact and Global Analysis by Produc …
Hormone Replacement Therapy is any form of hormone therapy where in the patient, in course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones. Menopause, is the time in most women's lives when menstrual periods stop permanently, and the woman is no longer able to have children. Menopause typically occurs between 45 and 55 years of age.
Critical Care Information Systems Market Key Players- Affiliated Computer Servic …
Critical care information systems are used to help manage the large amount of data generated in an intensive care unit every day. Obtaining, synchronizing, assimilating, and evaluating patient data is very difficult because of incompatibilities among monitoring equipment, the absence of standard data formatting and proprietary limitations from industry. The intensive care units are a specialized section of a hospital containing the equipment, medical and nursing staff, monitoring and life
Paper Cores Demand Catalyzes amid High Emphasis on Circular Economy: FMI Study
The global packaging industry has made remarkable progress in recent years, with numerous innovations and technological advances prioritized. Particular emphasis is placed on ensuring sustainability and the spread of the circular economy. Reliable benefits have been obtained in reducing the generation of municipal solid waste. Future Market Insights is a recently published research report that incorporates historical analysis from 2015 to 2019 and future assessments from 2020 to 2030 to
Endometrial Cancer Treatment Market Key Players- R-Pharm-US LLC., Bristol-Myers …
Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of women are diagnosed with the endometrial cancer at some point in their lives. According to National Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in the selection of proper treatment options.

All 5 Releases


More Releases for Oncology

International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and